Bodi Zhang

Bodi Zhang is a venture partner at NextGen Venture Partners and has held significant leadership roles in various organizations, including Chief Strategy Officer at Thorne HealthTech and founding team member at Nutrativa and Onegevity Health, both of which merged to form Thorne HealthTech. Zhang's expertise extends to advisory roles, having served on the Board of Distinguished Advisors for The Antibody Society. Previous positions include project manager at Deallus Consulting, research assistant professor at Tufts University School of Medicine, and equity analyst roles at Bosera Asset Management and Morgan Stanley. Zhang holds a Ph.D. in Pharmacology and Immunology from Tufts University, an MPH in Healthcare Management from Harvard T.H. Chan School of Public Health, and a Medical Degree from Peking University. Additional educational qualifications include a Mini-MBA from Harvard Business School, specializing in Healthcare Venture Capital and Entrepreneurship.